日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the Acute Effects of the Cannabinoid Dronabinol and the Opioid Hydromorphone Alone and in Combination: A Double-blind, Randomized, Placebo-controlled Trial in Knee Osteoarthritis

评估大麻素屈大麻酚和阿片类药物氢吗啡酮单独及联合用药对膝骨关节炎的急性疗效:一项双盲、随机、安慰剂对照试验

Hamilton, Katrina R; Mun, Chung Jung; Sadik, Eliot; Bergeria, Cecilia L; Huhn, Andrew S; Speed, Traci J; Vandrey, Ryan; Dunn, Kelly E; Campbell, Claudia M

Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder

赛拉嗪暴露与阿片类药物使用障碍患者早期生理和戒断症状的关联

Strickland, Justin C; Bergeria, Cecilia L; Huhn, Andrew S; McKendrick, Greer; Srungaram, Dhathri; Pattillo, Emma; Dunn, Kelly E

Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics

咖啡因和大麻二酚 (CBD) 联合给药对 Δ9-四氢大麻酚 (Δ9-THC) 的主观效应、性能损害和药代动力学的影响

Strickland, Justin C; Tilton, Hayleigh E; Patton, Noah M; Vandrey, Ryan; Austin Zamarripa, C; Spindle, Tory R; Lee, Dustin C; Bergeria, Cecilia L; Wolinsky, David; Klawitter, Jost; Sempio, Cristina; Campos-Palomino, Jorge; Christians, Uwe; Feldner, Matthew T; Irons, Jessica G; Bonn-Miller, Marcel O

A within-subject, double-blind, placebo-controlled randomized evaluation of the combined effects of cannabidiol and hydromorphone in a human laboratory pain model

一项在人体实验室疼痛模型中,采用受试者自身对照、双盲、安慰剂对照的随机研究,评估了大麻二酚和氢吗啡酮联合用药的效果。

Bergeria, Cecilia L; Mun, Chung Jung; Speed, Traci J; Huhn, Andrew S; Wolinsky, David; Vandrey, Ryan; Campbell, Claudia M; Dunn, Kelly E

US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis

美国毒品政策与专家对毒品危害的排名并不一致:一项多标准决策分析

Broman, Michael; Davis, Alan K; Armstrong, Stacey; Levin, Adam; Ahmed, Kaltum; Angarita, Gustavo A; Arterberry, Brooke J; Bergeria, Cecilia; Earleywine, Mitch; Gex, Kathryn S; Gregoire, Tom; Lister, Jamey J; Mathai, David S; Mehtani, Nicky J; Menke, Nathan; Nichols, Charles D; Shaub, Hillary; Tackett, Alayna P; Weiss, Brandon; Yalin, Nefize; Phillips, Lawrence D

Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment study

慢性疼痛成年人对阿片类药物和医用大麻的渴求:一项为期30天的生态瞬时评估研究的启示

Ellis, Jennifer D; Chipoletti, Ashley E; Tsang, Siny; Nordeck, Courtney D; Goodell, Erin M Anderson; Mun, Chung Jung; Martel, Marc O; Bergeria, Cecilia L; Dunn, Kelly E; Vandrey, Ryan; Thrul, Johannes; Finan, Patrick H

Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis

可卡因使用障碍药物治疗试验期间的可卡因渴求和使用情况:多轨迹分析

Mojtabai, Ramin; Susukida, Ryoko; Farokhnia, Mehdi; Nguyen, Trang Quynh; Leggio, Lorenzo; Bergeria, Cecilia; Dunn, Kelly E; Aminesmaeili, Masoumeh

Exploring Passion for Opioid Use with a Treatment-Seeking Sample: Results from a Canonical Correlation Analysis

利用典型相关分析探索寻求治疗人群对阿片类药物使用的热情

Park, Brandon; Davis, Alan K; Bergeria, Cecilia L; Xin, Yitong

'I crave not to feel uncomfortable' - investigating craving for opioids and cannabis among individuals with chronic pain

“我渴望摆脱不适感”——调查慢性疼痛患者对阿片类药物和大麻的渴望

Thrul, Johannes; Nordeck, Courtney D; Devkota, Janardan; Mun, Chung Jung; Dunn, Kelly E; Bergeria, Cecilia L; Zipunnikov, Vadim; Vandrey, Ryan; Finan, Patrick H

Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment

OPRM1基因A118G SNP的多态性导致不同的阿片类药物体验:一项人类实验室表型-基因型评估

Dunn, Kelly E; Huhn, Andrew S; Finan, Patrick H; Mange, Ami; Bergeria, Cecilia L; Maher, Brion S; Rabinowitz, Jill A; Strain, Eric C; Antoine, Denis